1. Home
  2. OSUR vs ACHV Comparison

OSUR vs ACHV Comparison

Compare OSUR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.94

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.38

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
ACHV
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.1M
172.0M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
OSUR
ACHV
Price
$2.94
$4.38
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$3.00
$14.67
AVG Volume (30 Days)
317.6K
1.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$167,064,000.00
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$7.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$2.00
52 Week High
$3.76
$6.03

Technical Indicators

Market Signals
Indicator
OSUR
ACHV
Relative Strength Index (RSI) 41.28 57.48
Support Level $2.80 $4.06
Resistance Level $2.96 $5.13
Average True Range (ATR) 0.11 0.43
MACD -0.03 0.04
Stochastic Oscillator 5.30 57.50

Price Performance

Historical Comparison
OSUR
ACHV

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: